Philip Timmerman

Philip Timmerman

Auto-generated profile, based on publicly available information

Philip Timmerman

European Bioanalysis Forum vzw

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 October 2020 in Bioanalysis
Verified
Journal Article
Closed access
JGJoanne Goodman
Joanne Goodman
KCKyra J Cowan
Kyra J Cowan
MGMichaela Golob
Michaela Golob
LKLars Karlsson
Lars Karlsson
UKUlrich Kunz
Ulrich Kunz
PTPhilip Timmerman
Philip Timmerman
In 2012, the European Bioanalysis Forum published a recommendation on biomarker method development and the bioanalysis of biomarkers in support of drug development. Since then, there has been signi...

17 March 2021 in Bioanalysis
Verified
Journal Article
Closed access
ALAnna Laurén
Anna Laurén
JGJoanne Goodman
Joanne Goodman
JBJonas Blaes
Jonas Blaes
JCJohn Cook
John Cook
KCKyra J Cowan
Kyra J Cowan
PTPhilip Timmerman
Philip Timmerman
Immunogenicity assays are required to evaluate anti-drug antibody (ADA) responses that can be generated against biotherapeutic modalities. Regulatory guidelines focus on clinical requirements, yet ...

18 September 2018 in Bioanalysis
Verified
Journal Article
Open access
SPSusanne Pihl
Susanne Pihl
BSBarry W A van der Strate
Barry W A van der Strate
MGMichaela Golob
Michaela Golob
LVLaurent Vermet
Laurent Vermet
BJBirgit Jaitner
Birgit Jaitner
PTPhilip Timmerman
Philip Timmerman
Critical reagents play a crucial role in ligand binding assays; the robustness and reliability of an assay is defined by the quality and long-term availability of these reagents. However, neither regulatory guidelines nor relevant scientific papers provide clear directions for set-up, life cycle management and, more importantly, the acceptance criteria required for the testing of the critical reagents for pharmacokinetic, biomarker and immunogenicity assays. The ambiguity from current guidelines can be a challenge for the bioanalytical community. Members of the European Bioanalysis Forum community undertook a more pragmatic approach on how to assess the impact of critical reagents. In this paper, a review and corresponding gap analysis of the current guidelines and relevant papers will be provided as well as decision trees proposed for lot-to-lot changes of critical reagents for pharmacokinetic assays.

21 August 2018 in Bioanalysis
Verified
Journal Article
Closed access
PTPhilip Timmerman
Philip Timmerman
MGMichaela Golob
Michaela Golob
JGJoanne Goodman
Joanne Goodman
MKMagnus Knutsson
Magnus Knutsson
RNRobert Nelson
Robert Nelson
SWSteve White
Steve White

1 August 2022 in Bioanalysis
Verified
Journal Article
Closed access
ALAnna Laurén
Anna Laurén
MBManuela Braun
Manuela Braun
CCChiara Cazzin
Chiara Cazzin
KCKelly Colleti
Kelly Colleti
CCChris Cox
Chris Cox
PTPhilip Timmerman
Philip Timmerman
In this manuscript, the European Bioanalysis Forum reports back on their discussions on practical and scientific considerations related to bioanalytical applications of quantitative polymerase chai...

1 March 2019 in Bioanalysis
Verified
Journal Article
Closed access
GHGlen Hawthorne
Glen Hawthorne
LDLieve Dillen
Lieve Dillen
MBMatthew Barfield
Matthew Barfield
ZCZoe Cobb
Zoe Cobb
AKAbdullah Kandira
Abdullah Kandira
PTPhilip Timmerman
Philip Timmerman
Aim: Microsampling in preclinical pharmacokinetics (PK) studies is currently widely adopted across the pharmaceutical industry. Materials & methods: The European Bioanalysis Forum liquid microsampling consortium member companies assessed the accuracy and precision of handheld pipettes and microcapillaries at volumes of less than 10 μl. The following key factors on pipetting performance were also evaluated: Pipette type (positive displacement, air displacement and microcapillary), experience of user and the liquid type. Water was selected as a best-case scenario for accuracy and precision determination and blood plasma as a ‘real world’ bioanalysis sample type. Conclusion: Accuracy and precision on the pipetted volume decreased at lower volumes and experienced laboratory technicians performed better compared with the infrequent users. With respect to the pipetting devices used, microcapillaries showed better or equivalent accuracy and precision compared with handheld pipettes across the volume range 1–8 μl...